This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents. Top assignees: Genome and Company, Lactomason Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seoul, KR (2023)
- Seongnam-si, KR (2023)
Company Filing History:
5 out of 9 
1 out of 4 Years Active: 2023-2026
Title: Innovations in Cancer Treatment by Inventor Yun Yeon Kim
Introduction
Yun Yeon Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 5 patents, his work focuses on developing novel strains and pharmaceutical compositions aimed at preventing and treating various cancers.
Latest Patents
One of his latest patents involves the MG731 strain, which has demonstrated effects in inhibiting the proliferation of cancer cells, decreasing their mobility, and enhancing the anticancer immune response. This strain also shows promise in reducing inflammatory factors, making it a potential candidate for treating cancers and inflammatory diseases. Additionally, when combined with anticancer chemotherapeutic or immunotherapeutic agents, the MG731 strain exhibits improved anticancer effects. Another significant invention is the GEN3033 strain, which directly inhibits cancer cell proliferation and enhances immunity. This strain secretes metabolites with anticancer properties while established in the gut, further improving its efficacy when used alongside other treatments. Lastly, he has developed a pharmaceutical composition that includes an LRIT2 inhibitor, which can enhance immune cell activity and effectively prevent or treat cancer by boosting the individual's immunity.
Career Highlights
Yun Yeon Kim has worked with notable companies such as Genome and Company and Lactomason Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and cancer research.
Collaborations
He has collaborated with esteemed colleagues, including Youn Kyung Houh and Hansoo Park, to advance his research and innovations in cancer treatment.
Conclusion
Yun Yeon Kim's innovative work in developing strains and pharmaceutical compositions for cancer treatment showcases his dedication to improving healthcare outcomes. His contributions are paving the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile